BioNTech Stock

Why Will BioNTech (BNTX) Stock Continue To Rise?

China is planning to authorize the COVID-19 vaccine developed by Germany's BioNTech by July. - April 18, 2021

Will Pfizer and BioNTech Become The Workhorse Of The EU's Vaccine Market?

Pfizer-BioNTech vaccine is marching towards the EU. - April 14, 2021

Why BioNTech Stock Sank Today | The Motley Fool

China suspends distribution, alleging defective packaging. - March 24, 2021

Pfizer to Develop mRNA Vaccines Without BioNTech | The Motley Fool

The pharmaceutical heavyweight thinks it won't need any more help to whip up new mRNA-based vaccines. - March 23, 2021

Why BioNTech Trounced the Market on Thursday | The Motley Fool

There was some excellent news about the company's most famous product. - March 11, 2021

Study: Pfizer and BioNTech Vaccine Neutralizes Brazil Coronavirus Variant | The Motley Fool

The two companies' BNT162b2 seems to protect patients against the fast-spreading variant. - March 09, 2021

Is BioNTech Stock a Buy? | The Motley Fool

The key ingredients are here for a multi-bagger over the next decade and beyond. - March 05, 2021

Pfizer and BioNTech Coronavirus Vaccine Effective After 1 Dose, Can Last 2 Weeks in Standard Freezer, Separate Research Shows | The Motley Fool

The new findings promise simpler transport, storage, and administration for BNT162b2. - February 19, 2021

Pfizer and BioNTech Launch Coronavirus Vaccine Study for Pregnant Women | The Motley Fool

The testing will also be extended to children. - February 18, 2021

Pfizer/BioNTech to Sell More COVID-19 Vaccine Doses to EU

Pfizer (PFE)/BioNTech (BNTX) win a deal for 200 million more doses of its COVID-19 vaccine in Europe. - February 18, 2021

BioNTech: Undervalued Based On COVID Vaccine Revenue (NASDAQ:BNTX)

BioNTech is undervalued and deserves a share price of $200 based on its earnings potential over the next five years. - February 10, 2021

Sanofi (SNY) to Manufacture BioNTech's Coronavirus Vaccine

Sanofi (SNY) to support manufacturing and supply of BioNTech's COVID-19 vaccine candidate, which the latter has developed in partnership with Pfizer. - January 28, 2021

Better Buy: Pfizer vs. BioNTech | The Motley Fool

Which stock will be the bigger winner between these two COVID-19 vaccine partners? - January 28, 2021

The Zacks Analyst Blog Highlights: Moderna, Pfizer, BioNTech and AstraZeneca

The Zacks Analyst Blog Highlights: Moderna, Pfizer, BioNTech and AstraZeneca - January 27, 2021